<html><head><link rel="stylesheet" type="text/css" href="css.css"></head><h1 id="artitle">Drug May Extend A.L.S. Patients’ Lives by Several Months, Study Finds<br></h1><p id="artcont">The two-drug combination invented by college students is one of many potential therapies being tested for this paralyzing fatal condition. By Pam Belluck A potential therapy for amyotrophic lateral sclerosis, a fatal neurological disorder, may allow patients to live several months longer than they otherwise would have, according to a study published Friday. The two-drug combination, dreamed up by two college students, is one of several potential treatments raising the hopes of patients with A.L.S., also known as Lou Gehrig’s disease. The paralytic condition steals people’s ability to walk, speak, eat and ultimately breathe, typically causing death within two to five years. 